DexCom (NASDAQ:DXCM – Get Free Report) was upgraded by stock analysts at Robert W. Baird from a “neutral” rating to an ...

Intermittent fasting is an effective method for weight loss and enhances cardiovascular health in individuals with obesity. A ...

A pair of deals in the fourth quarter of 2024 highlights the attraction of the patient-direct market for continuous glucose ...

Given differences in socioeconomic status and higher prevalence, the Black community face disproportionate outcomes in ...

A new error grid to assess the accuracy of glucose measurements could give continuous glucose monitor manufacturers and ...

SoFi Technologies (SOFI) rose for a third day on Thursday, adding 5.09 percent to close at $16.3 apiece as investors took ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $95.91, ...

The Nix hydration monitor offers clear performance benefits and the UCI approves it for competition. Why are some sensors ...

Stocks tend to perform well in January, but that's not a good reason to invest this month. Strong returns aren't made in a ...

In a report released today, Jeff Johnson from Robert W. Baird upgraded Dexcom (DXCM – Research Report) to a Buy, with a price target of ...

Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes, University of ...